CPT code 62367 represents a clinical service in which a provider evaluates the performance of an implantable intrathecal or epidural pump without performing reprogramming or medication refill. The code captures a focused device assessment procedure that supports ongoing management of patients receiving targeted intrathecal or epidural therapy for pain control or regional chemotherapy delivery. Nationally, accurate coding of device interrogation encounters affects clinical documentation, care coordination, and payer adjudication for high-cost implantable drug-delivery systems.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and typical sites of service, along with benchmarks and policy considerations relevant to coverage and billing for device performance analysis. The publication outlines common documentation elements that support appropriate use of CPT code 62367, highlights where payer policies commonly intersect with clinical practice, and summarizes relevant coding relationships and related services.

This summary is intended for a national audience of clinicians, coding professionals, and policy analysts who need a clear description of the service captured by CPT code 62367, the payers commonly involved, and the types of information that drive coverage and payment decisions. Data not available in the input is identified as such in the detailed sections.